The study, «Lenalidomide (LEN) maintenance (MNTC) after high - dose melphalan and autologous stem cell transplant (ASCT) in multiple myeloma (MM): A meta - analysis (MA) of overall survival (OS),» is ASCO 2016 abstract no. 8001 and will be discussed during the Hematologic Malignancies — Plasma Cell Dyscrasia oral abstract session Friday, June 3. (sciencedaily.com)
Shah and Shpall's team enrolled symptomatic patients who qualified as candidates for high - dose chemotherapy drugs like melphalan, and transplantation of the patient's own stem cells. (sciencedaily.com)
More recently, the chemotherapy agent melphalan has been described as having efficacy and the newer tyrosine kinase inhibitors (e.g. Palladia) may prove beneficial. (veterinarycancer.com)